Table 1

Clinical characteristics of patients with T-cell compared with B-cell acute lymphoblastic leukemia and overall survival in T-cell patients

T-cell ALL, n (%)B-cell ALL, n (%)*P5-year overall survival in T-cell ALL, percentage (95% CI)P
Group      
    ECOG 146 (41) 389 (34)  47 (39-56)  
    NRCI 210 (59) 758 (66)  48 (41-55)  
    P   .01  > .1 
Age, y      
    Younger than 20 55 (15) 256 (22)  53 (40-67)  
    20-29 136 (38) 311 (27)  52 (43-60)  
    30-39 85 (24) 216 (19)  46 (35-57)  
    40-49 46 (13) 203 (18)  47 (32-63)  
    50 or older 34 (10) 161 (14)  27 (11-43)  
    P   < .001/.06§  .009 
    35 or younger 244 (69) 704 (61)  52 (46-58)  
    Older than 35 112 (31) 443 (39)  38 (29-48)  
    P   .01  .004 
Sex      
    Male 260 (73) 680 (59)  50 (44-57)  
    Female 96 (27) 467 (41)  41 (31-51)  
    P   < .001  .05 
Diagnostic WBC, ×109/L      
    Less than 50 203 (58) 920 (81)  49 (42-56)  
    50-99 54 (15) 96 (8)  56 (42-69)  
    100 or more 96 (27) 125 (11)  41 (31-51)  
    P   < .001§  .09 (< 100 vs ≥ 100, P = .03
CNS involvement      
    Yes 32 (9) 46 (4)  47 (29-64)  
    No/unknown 324 (91) 1101 (96)  48 (42-54)  
    P   < .001/ < .001  > .1/> .1 
T-cell ALL, n (%)B-cell ALL, n (%)*P5-year overall survival in T-cell ALL, percentage (95% CI)P
Group      
    ECOG 146 (41) 389 (34)  47 (39-56)  
    NRCI 210 (59) 758 (66)  48 (41-55)  
    P   .01  > .1 
Age, y      
    Younger than 20 55 (15) 256 (22)  53 (40-67)  
    20-29 136 (38) 311 (27)  52 (43-60)  
    30-39 85 (24) 216 (19)  46 (35-57)  
    40-49 46 (13) 203 (18)  47 (32-63)  
    50 or older 34 (10) 161 (14)  27 (11-43)  
    P   < .001/.06§  .009 
    35 or younger 244 (69) 704 (61)  52 (46-58)  
    Older than 35 112 (31) 443 (39)  38 (29-48)  
    P   .01  .004 
Sex      
    Male 260 (73) 680 (59)  50 (44-57)  
    Female 96 (27) 467 (41)  41 (31-51)  
    P   < .001  .05 
Diagnostic WBC, ×109/L      
    Less than 50 203 (58) 920 (81)  49 (42-56)  
    50-99 54 (15) 96 (8)  56 (42-69)  
    100 or more 96 (27) 125 (11)  41 (31-51)  
    P   < .001§  .09 (< 100 vs ≥ 100, P = .03
CNS involvement      
    Yes 32 (9) 46 (4)  47 (29-64)  
    No/unknown 324 (91) 1101 (96)  48 (42-54)  
    P   < .001/ < .001  > .1/> .1 

NCRI indicates National Cancer Research Institute.

*

Excludes 29 mature B patients.

χ2 test for heterogeneity.

Log-rank test for heterogeneity.

§

χ2 test for trend.

Log-rank test for trend.

After controlling for WBC.

or Create an Account

Close Modal
Close Modal